Potentiation of platelet activation through the stimulation of P2X 1 receptors

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 12, 2003, Pages 2626-2635

  Erhardt, J A ^a   Pillarisetti, K ^a   Toomey, J R ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

; me atp; P2X 1; Platelet aggregation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENALIN; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; DRUG DERIVATIVE; HEPARIN; PURINE P2 RECEPTOR; PURINE P2X1 RECEPTOR; THROMBOPOIETIN;

ARTICLE; BLOOD CLOTTING PARAMETERS; CALCIUM SIGNALING; CELL SIZE; DRUG EFFECT; HUMAN; PHYSIOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESIVENESS;

ADENOSINE TRIPHOSPHATE; CALCIUM SIGNALING; CELL SIZE; EPINEPHRINE; HEPARIN; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET FUNCTION TESTS; RECEPTORS, PURINERGIC P2; THROMBOPOIETIN;

EID: 1542544887     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00453.x     Document Type: Article

References (37)

1. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409: 202-7.
2. Hoylaerts MF, Oury C, Toth-Zsamboki E, Vermylen J. ADP receptors in platelet activation and aggregation. Platelets 2000; 11: 307-9.
3. Jarvis GE, Humphries RG, Robertson MJ, Leff P. ADP can induce aggregation of human platelets via both P2Y (1) and P (2T) receptors. Br J Pharm 2000; 129: 275-82.
4. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999; 5: 1199-202.
5. Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y (1) receptor-null mice. J Clin Invest 1999; 104: 1731-7.
6. Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Pharm 1998; 103: 858-66.
7. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
8. 2T purinoceptors in human platelets. J Biol Chem 1996; 271: 2879-81.
9. 1 purinoceptor in human platelets: molecular cloning and functional characterization after het-erologous expression. J Biol Chem 1998; 273: 1544-7.
10. 1 purinoceptors with a,b-methy-lene ATP. Thromb Haemost 2001; 85: 303-8.
11. Koshimizu T, Koshimizu M, Stojilkovic SS. Contributions of the C-terminal domain to the control of P2X receptor desensitization. J Biol Chem 1999; 274: 37651-7.
12. 1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 2001; 86: 1264-71.
13. 1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors. Br J Pharmacol 2002; 135: 363-72.
14. 2+ influxon functional responses in human platelets. Thromb Haemost 2002; 88: 495-502.
15. 1-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 2002; 100: 2499-505.
16. 1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 2003; 101: 3969-76.
17. Westwick J, Scully MF, Poll C, Kakkar VV. Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro. Thromb Res 1986; 42: 435-47.
18. Ingall AH, Dixon J, Bailey A, Coombs ME, Cox D, McInally JI, Hunt SF, Kindon ND, Teobald BJ, Willis PA, Humphries RG, Leff P, Clegg JA, Smith JA, Tomlinson W. Antagonists of the platelet P2T receptor: a novelapproachtoantithrombotictherapy. J Med Chem 1999; 42: 213-20.
19. Storey RF, WilcoxRG, Heptinstall S. Differential effects of glycopro-tein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implica-tions for assay methodology and comparison of different antagonists. Circulation 1998; 98: 1616-21.
20. Matzdorff AC, Kuhnel G, Kemkes-Matthes B, Voss R. Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer. J Thromb Thrombolysis 2001; 12: 129-39.
21. Rodriguez-Linares B, Watson SP. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphoryla-tion. Biochem J 1996; 316: 93-8.
22. Kojima H, Hamazaki Y, Nagata Y, Todokoro K, Nagasawa T, Abe T. Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 1995; 74: 1541-5.
23. Steen VM, Holmsen H, Aarbakke G. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrena-line per se does not induce human platelet activation in vitro. Thromb Haemost 1993; 70: 506-13.
24. Oda A, Miyakawa Y, Druker BJ, Ozaki K, Yabusaki K, Shirasawa Y, Handa M, Kato T, Miyazaki H, Shimosaka A, Ikeda Y. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 1996; 87: 4664-70.
25. 3 receptors. Drug Dev Res 2001; 53: 281-91.
26. Baurand A, Raboisson P, Freund M, Leon C, Cazenave J, Bourguignon J, Gachet C. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharm 2001; 412: 213-21.
27. Jarvis GE, Humphries RG, Robertson MJ, Leff P. ADP can induce aggregation of human platelets via both P2Y (1) and P (2T) receptors. Br J Pharmacol 2000; 129: 275-82.
28. Thomson C, Forbes CD, Prentice CR. The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin Sci Mol Med 1973; 45: 485-94.
29. Yamamoto M, Watanabe K, Ando Y, Iri H, Handa H, Yoshii Y, Imai M, Sugiura K, Ikeda Y. On the mechanism of heparin-induced platelet aggregation. Thromb Res 1982; 26: 159-64.
30. Saba HI, Saba SR, Morelli GA. Effect of heparin on platelet aggrega-tion. Am J Hematol 1984; 17: 295-306.
31. Chen J, Sylven C. Heparin potentiation of collagen-induced aggregation is related to the GPIIb/GPIIIa receptor and not the GPIb receptor, as tested by whole blood aggregometry. Thromb Res 1992; 66: 111-20.
32. Schneider DJ, Tracy PB, Mann KG, Sobel BE. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation 1997; 96: 2877-83.
33. 1 purinoceptors on rat platelets: effect of clopidogrel. Br J Haematol 1997; 98: 880-6.
34. 1 purinoceptors for platelet aggregation. Eur J Pharm 1999; 372: 305-9.
35. 3. J Biol Chem 2001; 276: 42226-32.
36. 1 recep-tors. Nature 2000; 403: 86-9.
37. 1 receptor due to deletion of a single amino acid residue. J Biol Chem 2000; 275: 22611-4.